Ypsomed announced today that it concluded a long-term supply agreement with Novo Nordisk for large quantities of autoinjectors. Burgdorf, Switzerland-based Ypsomed designed the autoinjectors to administer drugs for the self-treatment of metabolic conditions. It intends to deliver variants of its YpsoMate 1mL autoinjector for various drugs undergoing clinical trials in large quantities. This expands its […]
Auto-injectors
8 drug delivery innovations you should know
Innovations in drug delivery never stop, and over the past 12 months or so a wide variety have been in the spotlight. Constant progress continues in the diabetes space, both in the form of insulin delivery and other drug delivery methods. Elsewhere, we see implants, patches, syringes and more showcasing the many ways we can […]
Ypsomed to expand drug delivery device manufacturing, add 200 jobs
Ypsomed announced today that, at its annual general meeting, its shareholders approved all proposals, including facility expansions. Burgdorf, Switzerland-based Ypsomed develops drug delivery devices, including insulin pumps for those with diabetes. Its YpsoPump represents a leading offering as an automated insulin delivery system compatible with certain software and glucose monitors. Board member Simon Michel confirmed […]
Ypsomed, S3 Connected Health partner to expand digital offerings
Ypsomed announced plans to expand its offerings of digital health solutions for chronic disease therapy together with S3 Connected Health. Dublin, Ireland-based S3 Connected Health specializes as a digital health partner for life science companies. This partnership allows Ypsomed’s biopharma customers to quickly launch therapy-specific digital patient solutions. It enables therapy management support for acute […]
Novo Nordisk looks to acquire a majority stake in BioCorp for $164.5M
Novo Nordisk announced today that it entered into exclusive negotiations for a controlling stake in drug delivery device maker Biocorp. France-based Biocorp specializes in the design, development and manufacturing of delivery systems and medical devices. Its offerings include Mallya, a Bluetooth-enabled smart add-on device for pen injectors. Mallya, a smart sensor, attaches directly to insulin […]
Dymax launches 1045-M adhesive for drug delivery devices
Dymax announced today that it released its 1045-M adhesive, the latest product in its line of MD light-curable materials for medical device assembly. Torrington, Connecticut-based Dymax designed MD 1045-M to bond glass, SS, ABS and PC substrates. Uses for these include assembling prefilled syringes and single-use devices. They also aid in the assembly of auto, […]
11 diabetes tech startups you need to know
The diabetes technology space is one that’s always innovating. From continuous glucose monitoring to insulin pumps and the artificial pancreas, we’ve seen a lot. Companies are looking for all kinds of ways to make their mark in the world of diabetes. Newer offerings include digital health, software, coaching and more. For companies still in their […]
Owen Mumford wins Pharmapack award for UniSafe auto-injector
Pharmapack Europe today announced that Owen Mumford Pharmaceutical Services received one of its 2023 Pharmapack Awards. The company received recognition in the “Drug Delivery Innovation” category for its UniSafe reusable, connected auto-injector. Woodstock, United Kingdom-based Owen Mumford designed UniSafe as a companion device for its UniSafe 1mL safety syringes. These devices deliver subcutaneous medication. UniSafe […]
The year ahead in diabetes care: what to expect in 2023
After a banner year for diabetes technology in 2022, there’s still plenty to look forward to in 2023. Throughout 2022, we saw a wide range of advancements in diabetes technology. We saw launches for next-generation technologies, exciting clinical trial results, rumored spinouts and acquisitions and more. You can read all about the biggest diabetes stories […]
Eitan Medical opens new manufacturing facility for wearable drug delivery platform
Eitan Medical announced today that it opened a new manufacturing facility at its headquarters to support drug delivery device production. Netanya, Israel-based Eitan intends for the facility to manufacture its Sorrel wearable drug delivery platform. That includes multiple device configurations, such as vial- and cartridge-based wearable injectors. On-site manufacturing supports Eitan’s production scale for its […]